Insider Transactions in Q2 2022 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2022
|
David Mark Mc Clung EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,525
-6.15%
|
$46,100
$4.31 P/Share
|
|
Jun 11
2022
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
842
-0.96%
|
$2,526
$3.76 P/Share
|
|
Jun 03
2022
|
John Markels |
BUY
Open market or private purchase
|
Direct |
6,784
+17.28%
|
$20,352
$3.69 P/Share
|
|
Jun 01
2022
|
H Stewart Parker |
BUY
Open market or private purchase
|
Direct |
5,000
+9.31%
|
$15,000
$3.6 P/Share
|
|
Apr 29
2022
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-0.15%
|
$560
$4.15 P/Share
|
|
Apr 25
2022
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.76%
|
$2,648
$4.83 P/Share
|
|
Apr 25
2022
|
Jason D. Fontenot SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-0.79%
|
$3,304
$4.83 P/Share
|
|
Apr 24
2022
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,976
-4.19%
|
$15,904
$4.7 P/Share
|